Brightside Health, a telemedicine platform in San Francisco that offers quick access to customized treatment, expert providers, ongoing support, and support for a wide range of mental health problems, has raised $50m in Series-B funding.
ACME Capital and Mousse Partners led the round. Existing investors Bullpen Capital and Triventures also participated.
Brightside Health’s founder and CEO is Brad Kittredge. The company specializes in telemedicine and is dedicated to delivering the highest quality mental health care. The company combines empathy and expertise with cutting-edge technology to provide a customized treatment experience for each member via video visits, unlimited messaging and ongoing support. The company’s care model includes precision psychiatry which is a clinically proven approach to therapy and continuous care monitoring by a network.
Brightside Health can treat all symptoms, even complex ones, and provides timely appointments at home that are available in as little time as 24 hours. Brightside Health offers convenient access to treatment via video visits, unlimited messaging and ongoing support. It also delivers medication. This helps people feel better quicker and lasts longer. Brightside Health follows evidence-based methods, which are guided by a network of world-class psychiatric providers, licensed therapists, and innovative support tools. They also follow clinically-proven protocols to provide effective care at scale. Members can track their progress online through check-ins, which are also monitored closely by providers. This allows them to ensure the efficacy and rapid intervention when needed.